Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Joep Schellens: Influence of Dexamethasone and Tocilizumab on Fibrinolysis in COVID-19
Joep Schellens/LinkedIn
Jun 2, 2026, 15:20

Joep Schellens: Influence of Dexamethasone and Tocilizumab on Fibrinolysis in COVID-19

Joep Schellens, PhD-student at Maastricht UMC+, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Thrombosis Research, adding:

”I’m excited to share my article, ‘Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the Maastricht cohort’, has been published in Thrombosis Research.

This publication outlines the influence of dexamethasone and tocilizumab treatment on coagulation and fibrinolysis in COVID-19 ICU patients.

Many thanks to my co-authors for their valuable contributions to this work!”

Title: Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort

Authors: Joep Schellens, Magdolna Nagy, Anne-Marije Hulshof, Frank van Rosmalen, René van Oerle, Thijs T.W. van Herpt, Teba Alnima, Mark M.G. Mulder, Dave Hellenbrand, Hugo ten Cate, Rob G.H. Driessen, Jan-Willem E.M. Sels, Iwan C.C. van der Horst, Yvonne M.C. Henskens, Bas C.T. van Bussel, Henri M.H. Spronk on behalf of the Dutch Covid and Thrombosis Coalition

Joep Schellens: Influence of Dexamethasone and Tocilizumab on Fibrinolysis in COVID-19

Stay updated on all scientific advances with Hemostasis Today.

Anne-Marije Hulshof Bas C.T. van Bussel Covid-19 Dave Hellenbrand Dexamethasone fibrinolysis Frank van Rosmalen Health Hematology Hemostasis Hemostasis News Hemostasis Today Henri M.H. Spronk Hugo ten Cate Iwan C.C. van der Horst Jan-Willem E.M. Sels Joep Schellens Magdolna Nagy Mark M.G. Mulder Medicine René van Oerle Rob G.H. Driessen Teba Alnima Thijs T.W. van Herpt thrombosis Thrombosis Research tocilizumab Yvonne M.C. Henskens
NewsFeed